VOYA Investment Management
CPRX

VOYA Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

VOYA Investment Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6M Buy
589,876
+22,435
+4% +$534K 0.02% 523
2025
Q4 		$13.2M Buy
567,441
+121,042
+27% +$2.7M 0.01% 590
2025
Q3 		$8.79M Buy
446,399
+89,498
+25% +$1.84M 0.01% 705
2025
Q2 		$7.74M Buy
356,901
+295,219
+479% +$6.97M 0.01% 809
2025
Q1 		$1.5M Buy
61,682
+9,266
+18% +$209K ﹤0.01% 1418
2024
Q4 		$1.09M Buy
52,416
+10,465
+25% +$225K ﹤0.01% 1551
2024
Q3 		$834K Buy
41,951
+3,085
+8% +$57.2K ﹤0.01% 1737
2024
Q2 		$602K Buy
38,866
+4,925
+15% +$76.7K ﹤0.01% 1897
2024
Q1 		$541K Sell
33,941
-5,994
-15% -$90.3K ﹤0.01% 1975
2023
Q4 		$671K Buy
39,935
+539
+1% +$7.37K ﹤0.01% 1911
2023
Q3 		$461K Sell
39,396
-235,934
-86% -$3.16M ﹤0.01% 2080
2023
Q2 		$3.7M Buy
275,330
+230,901
+520% +$3.32M ﹤0.01% 1120
2023
Q1 		$737K Sell
44,429
-11,940
-21% -$197K ﹤0.01% 1824
2022
Q4 		$1.05M Sell
56,369
-2,518
-4% -$38.8K ﹤0.01% 1615
2022
Q3 		$756K Buy
58,887
+21,436
+57% +$254K ﹤0.01% 1782
2022
Q2 		$263K Sell
37,451
-1,304
-3% -$9.56K ﹤0.01% 2248
2022
Q1 		$321K Hold
38,755
– – ﹤0.01% 2145
2021
Q4 		$262K Sell
38,755
-931
-2% -$6.12K ﹤0.01% 2374
2021
Q3 		$210K Hold
39,686
– – ﹤0.01% 2549
2021
Q2 		$228K Sell
39,686
-5,830
-13% -$30.1K ﹤0.01% 2533
2021
Q1 		$210K Buy
45,516
+2,983
+7% +$11.9K ﹤0.01% 2512
2020
Q4 		$142K Buy
42,533
+9,100
+27% +$30.6K ﹤0.01% 2500
2020
Q3 		$99K Hold
33,433
– – ﹤0.01% 2343
2020
Q2 		$154K Sell
33,433
-14,774
-31% -$66.4K ﹤0.01% 2244
2020
Q1 		$186K Hold
48,207
– – ﹤0.01% 2152
2019
Q4 		$181K Buy
48,207
+9,133
+23% +$42.7K ﹤0.01% 2407
2019
Q3 		$207K Hold
39,074
– – ﹤0.01% 2230
2019
Q2 		$150K Sell
39,074
-2,075
-5% -$8.96K ﹤0.01% 2372
2019
Q1 		$210K Hold
41,149
– – ﹤0.01% 2248
2018
Q4 		$79K Hold
41,149
– – ﹤0.01% 2437
2018
Q3 		$156K Hold
41,149
– – ﹤0.01% 2409
2018
Q2 		$128K Buy
41,149
+8,176
+25% +$24.8K ﹤0.01% 2468
2018
Q1 		$79K Hold
32,973
– – ﹤0.01% 2507
2017
Q4 		$129K Hold
32,973
– – ﹤0.01% 2454
2017
Q3 		$83K Hold
32,973
– – ﹤0.01% 2580
2017
Q2 		$91K Buy
+32,973
New +$68.8K ﹤0.01% 2599
2016
Q2 		– Sell
-42,497
Closed -$50K – 2562
2016
Q1 		$50K Hold
42,497
– – ﹤0.01% 2477
2015
Q4 		$104K Hold
42,497
– – ﹤0.01% 2476
2015
Q3 		$127K Hold
42,497
– – ﹤0.01% 2430
2015
Q2 		$176K Buy
+42,497
New +$169K ﹤0.01% 2520

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VOYA Investment Management's CPRX Position: Q1 2026 in Review

VOYA Investment Management increased its Catalyst Pharmaceutical (CPRX) stake by 4% in Q1 2026, buying an estimated $534K and bringing the position to 589,876 shares worth $14.6M. The position accounts for 0.02% of the portfolio, ranked #523.

VOYA Investment Management first reported a position in CPRX in Q2 2015 and has held it in 40 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • VOYA Investment Management held 589,876 shares of Catalyst Pharmaceutical worth $14.6M as of Q1 2026.
  • VOYA Investment Management bought 22,435 Catalyst Pharmaceutical shares in Q1 2026, an estimated $534K.
  • Catalyst Pharmaceutical made up 0.02% of VOYA Investment Management's portfolio in Q1 2026, its #523 holding.
  • VOYA Investment Management first reported a position in Catalyst Pharmaceutical in Q2 2015 and has held it in 40 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.